Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CanGarooRM
- Development stage
- Preclinical
- Lead developer
- Elutia
- Modality
- Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Administration
- Surgical Implant
01
Overview
CanGarooRM is a next-generation drug-eluting biologic envelope designed to stabilize and protect cardiovascular implantable electronic devices (CIEDs) such as pacemakers and neurostimulators. The envelope is composed of a natural extracellular matrix derived from porcine small intestine submucosa, which promotes regenerative healing by encouraging host cell migration and vascularized tissue formation. Uniquely, it incorporates a slow-release formulation of the antibiotics rifampin and minocycline within dissolvable polymer rings to reduce bacterial colonization on the device surface. This combination aims to lower infection risk associated with CIED implantation while supporting healthy tissue integration around the device[1][4][8]. Developed for use in cardiac rhythm management procedures, it is positioned as the first biologic (non-synthetic) antibiotic-eluting envelope in its market segment.
- Brand names
- CanGarooRM
- Other names
- CanGaroo RM Antibacterial EnvelopeCanGaroo RMCanGarooRM Antibiotic-Eluting Biomatrix
02
Targets
RNAP (Bacterial dna-dependent RNA polymerase)Bacterial Ribosome
Beyond the preview
Go deeper on CanGarooRM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CanGarooRM.